Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

ETHSX vs DLHIX overlap: 42% of top holdings shared

Bottom line

How much do ETHSX and DLHIX overlap?

42% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 51.5% of ETHSX's assets and 30.4% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.

DLHIX holds far more positions (108 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

ETHSXDLHIX
Weight overlap (top 25)42%
Shared holdings10
Weight in shared holdings51.5%30.4%
Total positions42108
Expense ratio1.18%0.96%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings ETHSX and DLHIX have in common

Holding% of ETHSX% of DLHIXOverlap
Eli Lilly & Co12.47%4.16%4.16%
AbbVie Inc6.46%4.19%4.19%
AstraZeneca PLC6.24%3.27%3.27%
UnitedHealth Group Inc5.49%3.88%3.88%
Roche Holding AG5.44%3.01%3.01%
Merck & Co Inc5.08%3.68%3.68%
Vertex Pharmaceuticals Inc3.38%1.66%1.66%
Gilead Sciences Inc3.34%3.54%3.34%
Boston Scientific Corp2.18%1.42%1.42%
Neurocrine Biosciences Inc1.41%1.57%1.41%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in ETHSX

  1. Johnson & Johnson — 6.45%
  2. Bristol-Myers Squibb Co — 4.25%
  3. Sanofi SA — 2.95%
  4. Thermo Fisher Scientific Inc — 2.79%
  5. Intuitive Surgical Inc — 2.72%
  6. Stryker Corp — 2.21%
  7. Medtronic PLC — 1.80%
  8. Lonza Group AG — 1.77%
  9. Novo Nordisk A/S — 1.71%
  10. Abbott Laboratories — 1.65%
  11. Novartis AG — 1.65%
  12. Argenx SE — 1.61%
  13. Royalty Pharma PLC — 1.58%
  14. Mettler-Toledo International Inc — 1.36%
  15. Straumann Holding AG — 1.34%

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Regeneron Pharmaceuticals Inc — 3.91%
  3. Pfizer Inc — 3.84%
  4. Elevance Health Inc — 3.25%
  5. Chugai Pharmaceutical Co Ltd — 2.77%
  6. Viatris Inc — 2.48%
  7. Oruka Therapeutics Inc — 2.41%
  8. Halozyme Therapeutics Inc — 2.30%
  9. Amgen Inc — 2.27%
  10. Illumina Inc — 2.11%
  11. Alkermes Plc — 1.82%
  12. Viking Therapeutics Inc — 1.72%
  13. Roivant Sciences Ltd — 1.60%
  14. Arcus Biosciences Inc — 1.56%
  15. Zimmer Biomet Holdings Inc — 1.42%

Asset mix

Asset typeETHSXDLHIX
Stocks99.4%94.8%
Preferred stock—3.0%
Cash & short-term funds0.3%2.0%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryETHSXDLHIX
US69.4%75.4%
CH10.2%3.0%
GB7.8%3.3%
BE—5.2%
FR3.2%2.0%
IE1.8%3.2%
DK2.9%—
JP—2.8%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do ETHSX and DLHIX overlap?
About 42% by weight. 10 securities appear in both funds' top 25 holdings; they make up 51.5% of ETHSX's assets and 30.4% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do ETHSX and DLHIX have in common?
The largest shared holdings are AbbVie Inc, Eli Lilly & Co, UnitedHealth Group Inc, Merck & Co Inc, Gilead Sciences Inc.
Should I own both ETHSX and DLHIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, ETHSX or DLHIX?
DLHIX is broader, with 108 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.